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Abstract 
AIM: The study aimed to evaluate serum vitamin D concentrations among neonates with pneumonia. 
METHODS: This case-control study enrolled 33 neonates with pneumonia in addition to 30 healthy controls. CBC, 
CRP, Serum vitamin D and Pentraxin 3 levels were measured for all participants. 
RESULTS: There was significant difference between patients and controls regarding Hemoglobin levels, TLC and 
CRP (p value < 0.01, = 0.002, < 0.01 respectively). Patients with pneumonia showed significant lower levels of 
Vit. D (9 ± 2.1) compared to controls (14.1 ± 2.8), P value < 0.01. However, patient group had significant higher 
levels of Pentraxin 3 (29.1 ± 4.8) compared with controls (12.6 ± 3), P value < 0.01. Moreover, mechanically 
ventilated patients revealed significant lower vit D (7.7 ± 1.8) and higher pentraxin 3 (32.2 ± 2.6) compared to 
patients on free oxygen (9.1 ± 2.1, 26.4 ± 3.7 respectively), P value = 0.05, 0.02 respectively. Regarding hospital 
stay, it had significant positive correlation with serum pentraxin 3 (r = 0.6, P value < 0.01) and significant negative 
correlation with serum vit D (r = -0.4, P value = 0.04). Finally a significant negative correlation between serum 
levels of vitamin D and Pentraxin 3 was found (r = -0.4, P value = 0.01). 
CONCLUSION: Lower concentration of serum vitamin D may be significantly associated with neonatal 
pneumonia. It also can predict the need for mechanical ventilation and duration of hospital stay in neonatal 
pneumonia. Similarly, higher levels of Pentraxin 3 may be used as an indicator for mechanical ventilation need 
and a longer hospital stay in neonates with pneumonia. 
 
 
 
 
Introduction 
 
Pneumonia is broadly defined as lung 
inflammation induced by an infectious agent who 
stimulates a response resulting in lung tissue damage 
[1]. Globally pneumonia accounts for nearly one in five 
deaths among children > 5 years of age [2]. Etiological 
factors for pneumonia vary according to age, source 
of infection (community or hospital-acquired 
pneumonia) and underlying host defects as 
immunodeficiency [3]. In neonatal periods, the 
underdeveloped immune system predisposes 
newborns, especially preterm to pulmonary infections, 
which is a major cause of death [4]. 
Vitamin D is a steroid hormone that has a 
great role in calcium and phosphorus homeostasis, 
bone metabolism and bone development [5], [6]. 
Recently the role of vitamin D on glucose 
homeostasis, cardiovascular diseases, immune 
system and cancer has been reported [7], [8].  
In adults, deficiency of vitamin D is associated 
with higher risks for many cancers, diabetes mellitus 
(DM), rheumatoid arthritis and multiple sclerosis [9].
 
In 
children and infants, Vitamin D insufficiency was 
reported to be associated with type 1 DM, allergies 
and atopic diseases (10). Also, children who 
manifested vitamin D deficiency as rickets were 
reported to have pneumonia [11]. 
Indeed, multiple reports suggested the vital 
role of vitamin D in immune system function and 
regulation since 1, 25 dihydroxy vitamin D can 
promote the innate immature response to the 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2                                                                                                                                                                                                   https://www.id-press.eu/mjms/index 
 
pathogen [12]. Besides, multiple studies have 
identified an association of respiratory infectious 
disease and inadequate serum vitamin D in non-
rachitic children [13], [14]. Biomarkers, applied in 
synergy with clinical signs and symptoms of 
pneumonia may provide extra data on disease 
severity and the differentiation between bacterial and 
viral aetiology [15], [16]. Pentraxin 3 is known as an 
acute-phase mediator that rapidly increases in 
inflammatory and infectious disorders [17], [18]. 
However, few studies regarding this link 
among neonates have been found. Given that this 
study was designed to evaluate the serum level of 25 
hydroxy-vitamin D in neonates with pneumonia and to 
assess its correlation with serum levels of Pentraxin 3 
as a mediator of acute inflammation. 
 
 
Subjects and Methods 
 
Thirty-three neonates diagnosed to have late-
onset pneumonia were recruited from NICU in El 
Galaa Teaching Hospital.30 healthy neonates of 
matched age and sex were enrolled as a control 
group. Parental written informed consent was 
obtained from all study participants and the study was 
approved by the medical ethical committee of the 
National Research Center, Cairo, Egypt. 
The inclusion criteria were as follows: age 
between day one and one month, clinical signs 
suggestive of pneumonia such as tachypnea, 
abnormal breath sounds, and radiological confirmation 
of pneumonia according to the WHO criteria for the 
standardised interpretation of pediatric chest 
radiographs for pneumonia diagnosis. Infants with 
underlying chronic respiratory disease were excluded 
from this study. 
All participants were subjected to full history 
taking and full clinical examination. Culture and 
sensitivity test was done to confirm the aetiology 
whether bacterial or nonbacterial pneumonia. Venous 
blood samples (3 cm) were taken from each infant 
participating in the study and were divided into two 
aliquots. The first aliquot 1 ml of venous blood was 
used for determination of CBC. The second aliquot 
2ml of venous blood was left to clot, and then the 
serum was separated by centrifugation and stored at 
−20°C for detection of serum vitamin D, Pentraxin 3 
and CRP levels. 
 
Statistical analysis 
Analysis of data was performed by using 
Statistical Package for the Social Science SPSS 
version 16.G. Data were presented as a mean and 
standard deviation. Chi-square test was conducted for 
detecting the significant difference in the distribution 
between categorical variables at P-value < 0.05. 
Continuous variables were compared by t-test (for 
normally distributed data). Spearman correlation was 
used to assess the correlations between non-normally 
distributed qualitative variables. 
 
 
Results 
 
The study group comprised 33 neonates with 
pneumonia aged 24.8 ± 4.6 days. They were 12 
(36.4%) males and 21 (63.6%) females. The mean of 
their gestational age was 37.5 ± 1.8 weeks and 11 of 
them (33.3%) delivered normally and 22 (66.7%) by 
caesarian section (CS). The study also included 30 
controls matched for age and sex with the patient 
group as delineated in Table 1. Regarding blood 
culture of cases, 22 neonates had positive blood 
cultures for bacteria: Staphylococcus aureus (30%), 
Klebsiella pneumonia (25%), Pseudomonas (20%), 
Acinetobacter (15%), E. coli (10%). 
When it comes to laboratory findings of both 
patient and control group, haemoglobin levels were 
significantly lower while TLC and CRP levels were 
higher in cases in comparison to controls. Patients 
with pneumonia also showed significantly lower levels 
of vitamin D compared to controls; however, the 
patient group had significantly higher levels of 
Pentraxin 3 compared to controls, (Table 1). 
Table 1: Demographic and laboratory data of the 
studied groups 
Descriptive data Items 
Cases 
n = 33 
(Mean ± SD) 
(Range) n (%) 
Control 
n = 30 
(Mean ± SD) 
(Range) n (%) 
 
Statistical test 
 
P- 
value 
Gestational age (Wks) 37.5 ± 1.8 37.7 ± 1.1 t = -0.5 0.6 
Age (days) 24.8 ± 4..6 26.1 ± 6.1 t = -0.7 0.5 
Mode of delivery 
NVD 
CS 
 
11 (33.3%) 
22 (66.7%) 
 
10 (33.3%) 
20 (66.7%) 

2 
= 0 1.0 
Sex 
Male 
Female 
 
12 (36.4%) 
21 (63.6%) 
 
14 (46.7%) 
16 (53.3%) 

2 
= 0. 7 0.4 
Hemoglobin (g/dl)  9.8 ± 1.4 13.3 ± 1.8 t = 4.2 < 0.01* 
TLC (× 10
9
/L) 12.2 ± 3.5 6.9 ± 1.6 t = 3.3 0.002* 
Serum CRP (mg/dl) 29.7 ± 4.2 4.1 ± 1.0 t = 5.1 < 0.01* 
Serum 25 (OH) D (µg/L) 9 ± 2.1 14.1 ± 2.8 t = -8 < 0.01* 
Serum Pentraxin3 (µg/L) 29.1 ± 4.8 12.6 ± 3 t = 3.7 < 0.01* 
*(P ≤ 0.05) is significant. 
 
According to Table 2, mechanically ventilated 
patients revealed significantly lower vitamin D and 
higher pentraxin 3 compared to free oxygen patients. 
Table 2: Comparison between serum vitamin D and Pentraxin3 
in mechanically ventilated patients and patients on free oxygen 
Variable 
Mechanically ventilated 
patients 
N = 14 
(Mean ± SD) 
 
Patients on free 
oxygen 
N = 19 
(Mean ± SD) 
 
P-value 
Serum 25 (OH) D (µg/L) 7.7 ± 1.8 9.1 ± 2.1 0.05* 
Serum Pentraxin3 (µg/L) 32.2 ± 2.6 26.4 ± 3.7 0.02* 
*(P ≤ 0.05) is significant. 
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Regarding hospital stay, it had significant 
negative correlation with serum vit D (r = -0.4, P value 
= 0.04) and significant positive correlation with serum 
pentraxin 3 (r = 0.6, P value < 0.01) and as delineated 
in Figure 1 (top), (middle) respectively. Finally a 
significant negative correlation between serum 
Vitamin D and Pentraxin 3 was found (r = -0.4, P 
value = 0.01) (Figure1: bottom). 
 
 
 
Figure 1: Correlation between serum vitamin D and a hospital stay 
of neonates with pneumonia (top); Correlation between serum 
Pentraxin 3 and hospital stay of neonates with pneumonia (middle); 
Correlation between serum vitamin D and Pentraxin 3 (bottom) 
 
Discussion 
 
The current case-control study aimed to study 
vitamin D in neonates with pneumonia, and the results 
showed that serum vitamin D was significantly lower 
among patients with pneumonia compared to controls 
and in patients on mechanical ventilation compared to 
patients on free oxygen. Also, serum vitamin D was 
negatively correlated with the duration of hospital stay. 
Similarly, (Lezhenko et al., 2016) reported that 
children at an early age with low levels of vitamin D 
are at risk for pneumonia since significant lower 
concentrations of 25-hydroxyvitamin D were detected 
in children with community-acquired pneumonia 
compared with healthy controls [19]. (Dinlen et al., 
2016) Also assessed serum 25 (OH) D levels in 
newborns with pneumonia and their mothers and 
observed a lower concentration compared to healthy 
newborns and their mothers [20]. In the same point of 
view (Mohamed and Al-Shehri, 2013) tested cord 
blood of 206 newborns for 25 (OH) D and reviewed 
their medical records during the early 2 years of life 
and noticed that lower level of 25 (OH) D in cord blood 
was associated with higher risk for acute lower 
respiratory tract infection (LRTI) in early life [21]. 
Indeed, deficiency of vitamin D in pregnant women 
has been reported to rise respiratory tract infection 
risk in their offspring as vitamin D can modulate the 
expression of specific tolerogenic genes during 
pregnancy that related to diseases other than 
congenital rickets [22], [23].  
The current hypothesis of lower vitamin D is a 
risk factor for neonatal pneumonia, and its poor 
prognosis can also be confirmed by the meta-analysis 
of (Charan et al., 2012) which showed that Vitamin D 
supplementation could decrease the events related to 
respiratory tract infections [24]. Besides the 
systematic review of (Christensen et al., 2017) 
reported that supplementation of vitamin D during 
pregnancy could prevent respiratory tract infection of 
offspring [25]. A more recent systematic review and 
meta-analysis of (Jat, 2017)showed a significant 
correlation between vitamin D concentrations and 
both the incidence and severity of LRTI [26]. 
In contrast to the current findings, (McNally et 
al., 2009) did not observe a difference in vitamin D 
levels between the children with LRTI and controls but 
vitamin D deficiency was noticed to be significantly 
associated with admission to the pediatric ICU [27]. 
Regarding pentraxin 3, it was significantly 
elevated in patients with pneumonia compared with 
controls and in mechanically ventilated patients 
compared to free oxygen ones. Moreover, it was 
positively correlated with the duration of hospital stay. 
Similarly, (Tekerek et al., 2018) detected higher levels 
of Pentraxin 3 among patients with ventilator-
associated pneumonia (VAP) compared to controls. 
[28]. By the same way, (Lin et al., 2013) reported that 
pentraxin 3 is a biomarker for VAP that correlated with 
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sepsis severity and was an independent predictor for 
VAP mortality by multivariate Cox regression analysis 
[29]. 
Finally, the present study was able to 
delineate a significant negative correlation between 
serum vitamin D and serum Pentraxin 3. Pentraxin 3 
is known as an inflammatory biomarker that can be 
easily used to assess the severity of lung injury [30], 
[31] and this noticed correlation can confirm the role of 
vitamin D in neonatal pneumonia. 
In conclusion, from the above results, it is now 
clear that inadequate concentrations of vitamin D in 
neonates may be associated with higher risks for 
pneumonia. Also, lowers levels can be a predisposing 
factor for the need for mechanical ventilation and 
longer hospital stay. So we can conclude that 
maternal prenatal/postpartum vitamin D 
supplementation may be a feasible primary preventive 
strategy to reduce pulmonary infections in the 
neonatal period. 
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